# RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
Canonical URL: https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum
Ticker: RXST
Company: RxSight
Source: RxSight
Published: 2026-06-25 13:46 EST
Original Source URL: https://investors.rxsight.com
## Summary

ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time.

## Article Body
ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time.
## Recent Company News
- 2026-06-25 13:46 EST — [RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum) — Source: RxSight
- 2026-06-25 13:46 EST — [RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook](https://biopharmsignal.com/news/RXST/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook) — Source: RxSight
- 2026-06-25 13:46 EST — [RxSight, Inc. to Present at the Piper Sandler Healthcare Conference](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-piper-sandler-healthcare-conference) — Source: RxSight
- 2026-06-25 13:46 EST — [RxSight, Inc. Announces Chief Financial Officer Transition](https://biopharmsignal.com/news/RXST/rxsight-inc-announces-chief-financial-officer-transition) — Source: RxSight
- 2026-06-25 13:46 EST — [RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-j-p-morgan-healthcare-conference) — Source: RxSight
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)